Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
insuline humaine soluble 100 unités/mL, cartouche de 3 mL de solution injectable |
Is a |
Soluble neutral insulin |
false |
Inferred relationship |
Some |
|
|
insuline humaine soluble 100 unités/mL, cartouche de 3 mL de solution injectable |
Is a |
Human insulin-containing product |
false |
Inferred relationship |
Some |
|
|
insuline humaine soluble 100 unités/mL, cartouche de 3 mL de solution injectable |
Is a |
Product containing short-acting insulin |
false |
Inferred relationship |
Some |
|
|
insuline humaine soluble 100 unités/mL, cartouche de 3 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pancreatic hormone |
false |
Inferred relationship |
Some |
|
|
insuline humaine soluble 100 unités/mL, cartouche de 3 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Human insulin |
false |
Inferred relationship |
Some |
|
|
insuline humaine soluble 100 unités/mL, cartouche de 3 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Short-acting insulin |
false |
Inferred relationship |
Some |
|
|
insuline humaine soluble 100 unités/mL, cartouche de 3 mL de solution injectable |
Is a |
Human insulin soluble-containing product |
false |
Inferred relationship |
Some |
|
|
insuline humaine soluble 100 unités/mL, cartouche de 3 mL de solution injectable |
Has manufactured dose form |
injection |
false |
Inferred relationship |
Some |
|
|
insuline humaine soluble 100 unités/mL, cartouche de 3 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Insulin |
false |
Inferred relationship |
Some |
|
|
insuline humaine soluble 100 unités/mL, cartouche de 3 mL de solution injectable |
Is a |
Product manufactured as parenteral dose form (product) |
false |
Inferred relationship |
Some |
|
|
insuline humaine soluble 100 unités/mL, cartouche de 3 mL de solution injectable |
Has manufactured dose form |
Solution for injection |
false |
Inferred relationship |
Some |
|
|